Purchase Order 75N91023P00657
Award Date 7/24/23
Potential Completion Date 9/23/23
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Wellesley Hills, Wellesley, MA 02481, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $13,950 purchase order to Intera Oncology Inc. to deliver infusion pumps in support of the agency's biomedical research efforts. Under the firm fixed price contract, Intera Oncology will provide the medical devices to the NCI location in Wellesley Hills, Massachusetts by September 29, 2023 to support research activities at that facility. No subcontractors or set aside...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $13,950 purchase order to Intera Oncology Inc. to deliver infusion pumps in support of the agency's biomedical research efforts. Under the firm fixed price contract, Intera Oncology will provide the medical devices to the NCI location in Wellesley Hills, Massachusetts by September 15, 2023. No set aside designation or subcontractors were identified. The award furthers the...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $13,950 purchase order to Intera Oncology Inc. of Wellesley Hills, Massachusetts for infusion pumps. The firm fixed price contract runs from August 28, 2023 through October 27, 2023 for the delivery of infusion pumps to support the NIH NCI's research efforts. No subcontractors or set aside designations were identified. Intera Oncology will provide the medical devices to the NIH NCI,...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a firm fixed price purchase order contract to Intera Oncology Inc., a for-profit organization, to provide infusion pumps and other laboratory equipment and supplies in support of cancer research efforts. The contract has a potential value of $14,390.00 and a completion date of May 20, 2024. No set-aside designation was used for this award. Intera Oncology Inc. has previously...
- The U.S. Department of Health and Human Services' National Cancer Institute (HHS-NIH-NCI) awarded a $14,390.00 firm fixed price purchase order contract to Intera Oncology Inc., a for-profit medical device and laboratory supply company. The contract is for the delivery of Intera3000 infusion pumps and other general laboratory equipment to support the NCI's cancer research programs, including clinical trials and standard care therapy for cancer patients. This contract does not have a set-aside...
- This is a $14,390.00 firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute (HHS-NIH-NCI) to Intera Oncology Inc., a for-profit organization, to provide laboratory supplies in support of cancer research efforts. The contract does not have a set-aside designation and was awarded directly to Intera Oncology Inc. as the prime contractor, with no mention of subcontractors. The purchase order includes the...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health within the U.S. Department of Health and Human Services, to Intera Oncology Inc., a for-profit medical device and laboratory supply company located in Newton, Massachusetts. The contract, valued at $14,790, is for the delivery of Intera3000 infusion pumps to support the NCI's cancer research and treatment programs. The contract does not have a...
- The National Institutes of Health, National Cancer Institute awarded a $404,725 firm fixed-price purchase order to Intera Oncology Inc. on April 13, 2026, for the procurement of Intera 3000 Hepatic Artery Infusion Pumps. The contract, which was not designated under any small business set-aside, was awarded through a sole-source justification based on market research confirming that the Intera 3000 is the only FDA-approved device available for the specified clinical indication. The pumps will...
- This is a $14,790 firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Intera Oncology Inc., a for-profit medical device and laboratory supply company located in Newton, Massachusetts. The contract is for the delivery of Intera3000 infusion pumps, which support the NCI's cancer research programs, clinical trials, and patient care initiatives. The contract has no set-aside designation,...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Intera Oncology Inc., a for-profit medical device and laboratory supply company located in Newton, Massachusetts. The contract is for the delivery of INFUSION PUMPs with a ceiling value of $14,790.00 and a period of performance through June 18, 2025. The contract was awarded on May 19, 2025 and does not have a set-aside...